Since Emergent was founded in 1998, it has participated in 6 rounds of funding. In total Emergent has raised $801.5M. Emergent's last funding round was on Aug 2020 for a total of $450.0M.
Emergent has 2 investors, including Medical CBRN Defense Consortium and National Institute of Allergy and Infectious Diseases. The latest investment occurred in Aug 2020.